President & CEO
Martin Stuart, Ph.D., is a serial entrepreneur who has enjoyed more than 30 years of commercial success introducing new and complex technologies to the Life Science and Healthcare markets.
Operating largely at the intersection of science and business, Martin’s forte transforms technology-driven companies into market-driven organizations with solid business acumen. No stranger to the start-up world, he has taken two companies from inception to more than $50M and ultimately exit through acquisition or public markets. He has built and managed sales channels in more than 40 countries worldwide, delivering commercial success.
Dr. Stuart spent 8+ years with Aperio Technologies, responsible for building commercial operations, including sales, marketing, and services. He championed several key initiatives, such as the Pathology Visions Conference, now the world's largest digital pathology industry conference. Also, He fostered the collaboration to digitize the world-famous pathology slide collection from Dr. Juan Rosai. These initiatives, coupled with solid, sustained, commercial growth, propelled Aperio to be the undisputed leader in the global digital pathology market. Aperio was acquired by Leica Biosystems, a Danaher Company, in 2012.
Dr. Stuart was awarded a Ph.D. from The University College of North Wales for his work on Ultra-High-Resolution Imaging of Langmuir Blodgett films and a BSc in Physics from London South Bank University, England.